Table 5. Risk groups: pretransplantation... | American Society of Hematology

Table 5.

Risk groups: pretransplantation clinical characteristics

Risk group	Age, y	Disease status	Cytogenetic risk
AML
Low	≥3	1st CR MRD⁻	Favorable
		1st CR MRD⁺
		2nd CR MRD⁻
Intermediate	≥3	1st CR MRD⁻	Intermediate/poor
		1st CR MRD⁺
		2nd CR MRD⁻
		2nd CR MRD⁺	Favorable
		Not in remission	Favorable
	<3	1st CR MRD⁻	Favorable
		1st CR MRD⁺
		2nd CR MRD⁻
		2nd CR MRD⁺
High	≥3	2nd CR MRD⁺	Intermediate/poor
	<3	1st CR MRD⁻	Intermediate/poor
		1st CR MRD⁺
		2nd CR MRD⁻
		Not in remission	Favorable
Very high	≥3	Not in remission	Intermediate/poor
	<3	2nd CR MRD⁺	Intermediate/poor
	<3	Not in remission	Intermediate/poor
ALL
Low	≥2	1st CR MRD⁻	Any
Low	≥2	1st CR MRD⁺	Any
Intermediate	≥2	≥2nd CR MRD⁻	Any
	≥2	≥2nd CR MRD⁺	Any
	<2	1st CR MRD⁻	Any
	<2	1st CR MRD⁺	Any
High	≥2	Not in remission	Any
	<2	≥2nd CR MRD⁻	Any
		≥2nd CR MRD⁺
		Not in remission

Risk group	Age, y	Disease status	Cytogenetic risk
AML
Low	≥3	1st CR MRD⁻	Favorable
		1st CR MRD⁺
		2nd CR MRD⁻
Intermediate	≥3	1st CR MRD⁻	Intermediate/poor
		1st CR MRD⁺
		2nd CR MRD⁻
		2nd CR MRD⁺	Favorable
		Not in remission	Favorable
	<3	1st CR MRD⁻	Favorable
		1st CR MRD⁺
		2nd CR MRD⁻
		2nd CR MRD⁺
High	≥3	2nd CR MRD⁺	Intermediate/poor
	<3	1st CR MRD⁻	Intermediate/poor
		1st CR MRD⁺
		2nd CR MRD⁻
		Not in remission	Favorable
Very high	≥3	Not in remission	Intermediate/poor
	<3	2nd CR MRD⁺	Intermediate/poor
	<3	Not in remission	Intermediate/poor
ALL
Low	≥2	1st CR MRD⁻	Any
Low	≥2	1st CR MRD⁺	Any
Intermediate	≥2	≥2nd CR MRD⁻	Any
	≥2	≥2nd CR MRD⁺	Any
	<2	1st CR MRD⁻	Any
	<2	1st CR MRD⁺	Any
High	≥2	Not in remission	Any
	<2	≥2nd CR MRD⁻	Any
		≥2nd CR MRD⁺
		Not in remission